Immunotherapy for advanced renal cell cancer-Reference-Cited by-同舟云学术

Immunotherapy for advanced renal cell cancer

Published:2015-12-29 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Coppin Chris¹,Porzsolt Franz²,Autenrieth Michael³,Kumpf Julia⁴,Coldman Andrew⁵,Wilt Timothy J⁶

Affiliation:

1. BC Cancer Agency Vancouver Island Centre; Medical Oncology; 2410 Lee Avenue Victoria BC Canada V8R 6V5

2. University of Ulm; Clinical Economics, Institute of History, Philosophy and Ethics in Medicine; Frauensteige 6 Ulm Germany 89075

3. Universität Ulm; Dept of Medicine; Ulm Baden-Wurttemberg Germany

4. Univeristat Ulm; Ulm Baden-Wurttemberg Germany

5. British Columbia Cancer Agency; Vancouver BC Canada

6. Minneapolis VA Medical Center; General Internal Medicine (111-0); One Veterans Drive Minneapolis Minnesota USA 55417

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD001425.pub3/fullpdf

Reference220 articles.

1. Randomized phase II/III trial of interferon alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma: the European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951);Aass;Journal of Clinical Oncology,2005

2. Interferon-a-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma: results of a randomized phase II study (EORTC 30951);Fossa;Cancer,2004

3. Active specific immunotherapy of renal cell carcinoma patients: a prospective randomized study of hormono-immuno-versus hormonotherapy. Preliminary report of immunological and clinical aspects;Adler;Journal of Biological Response Modifiers,1987

4. SC-interleukin-2 and sc-interferon-alpha therapy in combination with iv-5-fluorouracil in metastatic renal cell carcinoma;Anton,1996

5. A randomized clinical trial comparing sc interleukin-2, sc alpha-2a-interferon, and iv bolus 5-flurouracil against oral tamoxifen in progressive metastatic renal cell carcinoma patients;Atzpodien,1997

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis;European Urology Open Science;2022-03

2. Renal cell carcinoma therapy: Current and new drug candidates;Drug Discovery Today;2022-01

3. Astragalus-mediated stimulation on antigen-presenting cells could result in higher IL-21 production from CXCR5+ Tfh-like cells and better IL-21-mediated effector functions;Human Immunology;2021-06

4. Interleukin-2 as immunotherapeutic in the autoimmune diseases;International Immunopharmacology;2020-04